142280.KQ Green Cross Medical Science Corporation

Healthcare Health Care Equipment & Supplies KOSDAQ
3,085 KRW
Close of Oct 30, 2026
2,200 6,660
Market cap
KRW 73.9B
P/E
-
P/B
1.37x
ROE
-14.4%
Dividend yield
-
Fundamental score
0.9/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 142280.KQ undervalued?

Graham number

The Graham number of Green Cross Medical Science Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Green Cross Medical Science Corporation fundamental analysis

5 of 21 checks passed

ROE 0/2

Low return on equity (-14.4%), below 10%.

ROA 0/1

Return on assets (-8.0%) is below the industry median (6.2%).

Profit Consistency 1/2

Profitable for 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (2.2%) is above the 5-year average (-12.0% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (2.2%) is above the industry median (0.5%).

Revenue Growth 0/2

Revenue shrank 1.4% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Cash Runway 0/2

Cash covers 0.1 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book (1.4x) is above the industry median (0.7x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Green Cross Medical Science Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Green Cross Medical Science Corporation

GC Medical Science Corporation operates as a diagnostic medical device company in the vitro diagnostic industry in South Korea and internationally. The company's products include human healthcare products for the diagnosis of diabetes, non-communicable diseases, respiratory diseases, and vector borne diseases. It offers CERA-CHEK 1Code and CERA-CHEK 1070 for diabetes; GREENCARE A1c for HbA1c, CERA-CHEK 3 in 1 GHL for multi-diagnosis; CERA-CHEK Lactate; GREENCARE Hb and CERA-…

Full company profile